Navigation Links
Osteoporosis may be treated with strontium ranelate

UK had licensed the use of strontium ranelate to be used for treating patients with osteoporosis//, but scientists caution that before prescribing the drug it is important to observe the changes in the bone mineral density.

A study in the British Medical Journal has said that the drug strontium ranelate have an effect on the bone mineral density and notes that this effect can be used in advantage of the treatment procedure. The recent studies on the drug had shown the drug to be effective in treating both vertebral and non-vertebral fractures that happen in osteoporosis. In the treatment, strontium, the natural trace mineral that is present in the bones is simply returned to the bodies with the drug administration. The drug had showed good tolerance in the clinical trials with little side effects.

However, the researchers feel that the drug had not been tested enough on humans to find out how long the effects of the drug remain in the bones once the treatment is stopped. Also it needs to be seen if in the long term the mineral density of the bones remain the same or gets altered again after the treatment is discontinued.

Reference: British Medical Journal, June 2005
'"/>




Page: 1

Related medicine news :

1. New treatment for Osteoporosis
2. Osteoporosis in men
3. Osteoporosis Drugs: right time to take-off
4. Fluoride Found Effective in Osteoporosis
5. Mutation connected to Osteoporosis
6. Osteoporosis associated with Childhood Cancer
7. A treatment for Osteoporosis
8. Osteoporosis could be caused by irregular periods
9. Back exercises reduces Osteoporosis
10. Osteoporosis and kidney stones gene marker identified
11. The Answer To Prevent Osteoporosis
Post Your Comments:
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 1VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 2VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 3VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 4VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference 60314 5CHEENY KUM 3A The Mobile Online Way to Monitor Diabetes 60310 1CHEENY KUM 3A The Mobile Online Way to Monitor Diabetes 60310 2Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 1Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 14642 2